PATENT CLAIM ANALYSIS

Application Number: 16011085
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "464000"]

Abstract:
Technologies are described for formulations and methods to produce sublingual antidepressant and antianxiety tablets. The tablets may comprise sublingual tablet base and ketamine. The tablets may comprise 2.00 weight percent to 23.00 weight percent ketamine. The methods may comprise placing sublingual tablet base into a chamber. The methods may comprise adding a first ingredient into the chamber. The first ingredient may include ketamine. The methods may comprise mixing the first ingredient into the sublingual tablet base in the chamber to form a mixture. The methods may comprise pressing the mixture into a mold. The methods may comprise drying the mixture in the mold to form the tablet.

Claim (Index 11):
The method of  claim 10 , further comprising, prior to pressing the mixture into the mold:\n adding a second ingredient to the chamber, wherein the second ingredient includes a flavor; and mixing the second ingredient with the mixture in the chamber.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 2.9
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15431242', '15148106', '15903615', '15903529', '15728695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6612060898691582
- 35 USC 102 Novelty (BERT): 0.5097063758982715
- Combined Prediction Score: 0.6460561184720695
- Mean Citation Score: 176.96952199999996
- Max Citation Score: 311.6280799999999
- Similarity Product: 285.2379588913583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test